Johnson & Johnson is now required to add new warnings to Invokana about the risk of foot and leg amputations.The FDA provide the following signs to be aware of….
Patients taking canagliflozin should notify your health care professionals right away if you develop new pain or tenderness, sores or ulcers, or infections in your legs or feet. Talk to your health care professional if you have questions or concerns. Do not stop taking your diabetes medicine without first talking to your health care professional.
Health care professionals should, before starting canagliflozin, consider factors that may predispose patients to the need for amputations. These factors include a history of prior amputation, peripheral vascular disease, neuropathy, and diabetic foot ulcers. Monitor patients receiving canagliflozin for the signs and symptoms described above and discontinue canagliflozin if these complications occur.
If you or someone you love suffered an amputation, cardiovascular problems, ketoacidosis or other serious injuries as a result of taking Invokana, Invokamet or Invokamet XR, you may be entitled to compensation through an Invokana lawsuit.
Please contact attorney Jamie Sheller Esq. for a free consultation 1 800 883 2299
http://www.reuters.com/article/us-health-diabetes-johnson-johnson-idUSKCN18C2RC
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.